1-3 of 3
Joseph R. Testa
Close
Sort by
Journal Articles

Detecting Clonal Evolution in CLL Patients Treated with Targeted Therapies Versus Chemotherapy Utilizing Cytogenetic Microarray Analysis

James M. Martin, MD, Jordan Senchak, MD, Karen Ruth, MS, Joseph R. Testa, PhD, Essel D. Al-Saleem, MD, Jianming Pei, MD, Stefan Klaus Barta, MD MRCP, MS, Richard I. Fisher, MD, Nadia Khan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5544.
https://doi.org/10.1182/blood-2018-99-119619
Published: 2018
Journal Articles

Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B

Shuyun Rao, Sang-Yun Lee, Alejandro Gutierrez, Jacqueline Perrigoue, Roshan J. Thapa, Zhigang Tu, John R. Jeffers, Michele Rhodes, Stephen Anderson, Tamas Oravecz, Stephen P. Hunger, Roman A. Timakhov, Rugang Zhang, Siddharth Balachandran, Gerard P. Zambetti, Joseph R. Testa, A. Thomas Look, David L. Wiest
Journal: Blood
Blood (2012) 120 (18): 3764–3773.
https://doi.org/10.1182/blood-2012-03-415349
Published: 2012
Includes: Supplemental data
Journal Articles

Pten Inactivating Mutations Promote Loss of MYC “Oncogene Addiction” in a Conditional Zebrafish Model of T-ALL.

Alejandro Gutierrez, M.D., Hui Feng, Adele Faucherre, Jeroen Den Hertog, Edward V. Prochownik, MD, PhD, Joseph R. Testa, PhD, John Kanki, A. Thomas Look, MD
Journal: Blood
Blood (2009) 114 (22): 3977.
https://doi.org/10.1182/blood.V114.22.3977.3977
Published: 2009